Business Context and Reporting Period
This Form 6-K filing by GSK plc (the "Company") reports a transaction in its own shares conducted on October 3, 2025, and filed on October 6, 2025. The Company, a foreign private issuer, executed a share repurchase through BNP Paribas SA as part of an existing buyback programme established under a non-discretionary agreement announced on September 30, 2025.
Key Financial Metrics and Transaction Details
The filing details a specific block of share purchases rather than providing comprehensive financial statements (revenue, profit, or cash flow are not included in this document).
- Shares Purchased: 350,000 ordinary shares of 31½ pence each.
- Price Range: Lowest price paid was 1,598.00p; highest price paid was 1,649.00p.
- Volume-Weighted Average Price (VWAP): 1,631.45p.
- Trading Venues: Purchases were executed across BATE, CHIX, and XLON.
- Treasury Holdings: Following this transaction, the Company holds 248,716,844 ordinary shares in treasury.
- Shares in Issue: 4,066,691,695 ordinary shares (excluding Treasury shares).
- Voting Rights: Treasury shares represent 6.12% of total voting rights.
Material Changes and Programme Progress
Since the commencement of the current non-discretionary agreement on September 30, 2025, the Company has purchased an aggregate of 1,252,000 ordinary shares. The transaction reported herein represents the most recent activity within this programme. The filing confirms that the purchased shares are held as Treasury shares and do not carry voting rights.
Guidance, Outlook, and Risks
The filing contains no new financial guidance, management commentary on operational performance, or specific outlook statements. It includes a standard cautionary statement regarding forward-looking statements, noting that actual results may differ materially from projections due to risks described in the Company's 2024 Annual Report on Form 20-F and Q2 2025 Results.
Investor Verification Checklist
- Verify the total remaining authorization under the existing buyback programme to assess future repurchase capacity.
- Confirm the impact of the 6.12% treasury holding on earnings per share (EPS) calculations.
- Review the September 30, 2025 announcement for the total scope and duration of the non-discretionary agreement.
- Check subsequent filings for updates on the aggregate number of shares repurchased under the programme.